| |
| |
|
| Insider
Information: |
Perceptive Life Sciences Master Fund Ltd |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
12 |
|
| Direct
Shares |
2,270,404 |
|
|
Indirect Shares
|
99,979,160 |
|
|
| Direct
Value |
$1,360,880 |
|
|
|
Indirect Value
|
$310,399,383 |
|
|
| Total
Shares |
102,249,564 |
|
|
| Total
Value |
$311,760,264 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2008-09-29 |
0 |
2008-10-24 |
6,422,846 |
Premium* |
|
|
XTL Biopharmaceuticals Ltd |
XTLBY |
10% Owner |
2008-11-19 |
0 |
2008-11-19 |
20,580,260 |
Premium* |
|
|
Optimer Pharmaceuticals Inc |
OPTR |
10% Owner |
2008-07-02 |
0 |
2008-07-02 |
113,442 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-07-01 |
26,666,667 |
Premium* |
|
|
Aegerion Pharmaceuticals, Inc. |
AEGR |
10% Owner |
2012-12-04 |
0 |
2013-09-05 |
2,823,426 |
Premium* |
|
|
Acelrx Pharmaceuticals Inc |
ACRX |
10% Owner |
2013-07-23 |
0 |
2016-09-29 |
5,386,410 |
Premium* |
|
|
Amicus Therapeutics Inc |
FOLD |
10% Owner |
2014-06-30 |
0 |
2016-12-30 |
16,293,847 |
Premium* |
|
|
VBI Vaccines Inc |
VBIV |
10% Owner |
2014-07-25 |
2,270,404 |
2016-12-06 |
6,213,314 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
10% Owner |
2015-10-20 |
0 |
2017-02-14 |
2,589,451 |
Premium* |
|
|
Aravive Inc |
ARAV |
10% Owner |
2016-12-29 |
0 |
2017-02-13 |
4,228,563 |
Premium* |
|
|
Corium International, Inc. |
CORI |
10% Owner |
2017-05-25 |
0 |
2017-05-25 |
5,546,129 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
10% Owner |
|
0 |
2020-09-22 |
3,114,805 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ATHA |
Athira Pharma, Inc. |
10% Owner |
– – • |
2020-09-22 |
4 |
B |
$17.00 |
$18,000,008 |
I/I |
1,058,824 |
3,114,805 |
1.5 |
- |
|
| ATHA |
Athira Pharma, Inc. |
10% Owner |
– – • |
2020-09-22 |
4 |
A |
$0.00 |
$0 |
I/I |
1,644,785 |
2,055,981 |
0 |
- |
|
| ATHA |
Athira Pharma, Inc. |
10% Owner |
– – • |
2020-09-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
411,196 |
|
- |
|
| CORI |
Corium International, Inc... |
10% Owner |
– – • |
2017-05-25 |
4 |
B |
$6.25 |
$11,890,000 |
I/I |
1,902,400 |
5,546,129 |
1.5 |
- |
|
| CORI |
Corium International, Inc... |
10% Owner |
– – • |
2017-05-19 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,643,729 |
|
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2017-02-14 |
4 |
B |
$4.50 |
$4,018,613 |
I/I |
893,025 |
2,589,451 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2017-02-13 |
4 |
B |
$15.51 |
$917,425 |
I/I |
59,133 |
4,228,563 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2017-02-10 |
4 |
B |
$14.94 |
$521,281 |
I/I |
34,883 |
4,169,430 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2017-02-09 |
4 |
B |
$14.27 |
$587,928 |
I/I |
41,211 |
4,134,547 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2017-02-08 |
4 |
B |
$13.51 |
$1,413,319 |
I/I |
104,612 |
4,093,336 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2016-12-30 |
4/A |
B |
$14.66 |
$1,041,641 |
I/I |
71,063 |
3,989,724 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2016-12-30 |
4 |
B |
$4.96 |
$470,055 |
I/I |
94,750 |
16,293,847 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2016-12-30 |
4 |
B |
$14.66 |
$1,388,846 |
I/I |
94,750 |
4,013,411 |
1.5 |
- |
|
| ARAV |
Aravive Inc |
10% Owner |
– – • |
2016-12-29 |
4 |
B |
$14.37 |
$680,589 |
I/I |
47,375 |
3,918,661 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2016-12-29 |
4 |
B |
$4.85 |
$459,917 |
I/I |
94,750 |
16,293,847 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2016-12-28 |
4 |
B |
$4.91 |
$232,706 |
I/I |
47,375 |
16,199,097 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2016-12-23 |
4 |
B |
$4.72 |
$410,050 |
I/I |
85,275 |
16,151,722 |
1.5 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
10% Owner |
– – • |
2016-12-22 |
4 |
B |
$4.51 |
$854,835 |
I/I |
189,500 |
16,066,447 |
1.5 |
- |
|
| VBIV |
VBI Vaccines Inc |
10% Owner |
– – • |
2016-12-06 |
4 |
B |
$3.05 |
$10,321,063 |
I/I |
3,383,955 |
6,213,314 |
1.5 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
10% Owner |
– – • |
2016-09-29 |
4 |
S |
$3.88 |
$377,117 |
I/I |
(97,200) |
5,386,410 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
10% Owner |
– – • |
2016-09-28 |
4 |
S |
$3.96 |
$472,380 |
I/I |
(119,300) |
5,483,610 |
0 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
10% Owner |
– – • |
2016-09-15 |
4 |
S |
$3.63 |
$1,452,811 |
I/I |
(392,850) |
5,602,910 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
No longer a 10% Owner. |
– – – |
2016-08-25 |
4 |
S |
$6.81 |
$7,491,000 |
I/I |
(1,100,000) |
14,139,444 |
0 |
- |
|
| ALDX |
Aldeyra Therapeutics, Inc... |
10% Owner |
– – • |
2016-05-26 |
4 |
B |
$5.00 |
$3,500,000 |
I/I |
700,000 |
1,940,458 |
1.5 |
- |
|
| ACRX |
Acelrx Pharmaceuticals In... |
10% Owner |
– – • |
2015-11-18 |
4 |
S |
$5.35 |
$226,132 |
I/I |
(42,300) |
5,995,760 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
